We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$97.6B
AUM Growth
-$1.7B
Cap. Flow
-$3.16B
Cap. Flow %
-3.24%
Top 10 Hldgs %
14.39%
Holding
3,772
New
78
Increased
2,174
Reduced
812
Closed
154

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$382M
2
HSP
HOSPIRA INC
HSP
+$235M
3
MRK icon
Merck
MRK
+$227M
4
AGN
Allergan Inc
AGN
+$199M
5
AXP icon
American Express
AXP
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 19.47%
2 Financials 16.8%
3 Industrials 9.81%
4 Technology 8.84%
5 Energy 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACW
2926
DELISTED
Accuride Corp
ACW
$122K ﹤0.01%
26,242
+2,283
+10% +$10.8K
IBP icon
2927
Installed Building Products
IBP
$6.47B
$121K ﹤0.01%
5,554
+1,074
+24% +$20.3K
MRTX
2928
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$121K ﹤0.01%
4,136
+1,434
+53% +$33.6K
ECOM
2929
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$121K ﹤0.01%
12,447
+1,574
+14% +$17.5K
STML
2930
DELISTED
Stemline Therapeutics, Inc.
STML
$121K ﹤0.01%
8,379
+2,727
+48% +$41.7K
SNBC
2931
DELISTED
Sun Bancorp Inc
SNBC
$121K ﹤0.01%
6,399
+884
+16% +$16.4K
CBRE icon
2932
CBRE Group
CBRE
$43.1B
$120K ﹤0.01%
3,092
-86
-3% -$2.96K
PZN
2933
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$120K ﹤0.01%
13,054
+2,092
+19% +$18K
SNMX
2934
DELISTED
Senomyx, Inc.
SNMX
$120K ﹤0.01%
27,265
+2,674
+11% +$14K
CDI
2935
DELISTED
CDI Corp.
CDI
$120K ﹤0.01%
8,539
+1,222
+17% +$20K
CYTR
2936
DELISTED
CytRx Corp
CYTR
$120K ﹤0.01%
5,925
+737
+14% +$13.7K
CHRW icon
2937
C.H. Robinson
CHRW
$20B
$119K ﹤0.01%
1,632
NGVC icon
2938
Vitamin Cottage Natural Grocers
NGVC
$744M
$119K ﹤0.01%
4,315
+740
+21% +$21.1K
WEYS icon
2939
Weyco Group
WEYS
$374M
$119K ﹤0.01%
3,992
+584
+17% +$16.3K
ASPS icon
2940
Altisource Portfolio Solutions
ASPS
$58.1M
$118K ﹤0.01%
1,149
+200
+21% +$33.3K
ESCA icon
2941
Escalade
ESCA
$275M
$118K ﹤0.01%
6,781
+1,035
+18% +$16.4K
TREC
2942
DELISTED
Trecora Resources
TREC
$118K ﹤0.01%
9,689
+1,957
+25% +$26.9K
RNWK
2943
DELISTED
RealNetworks Inc
RNWK
$118K ﹤0.01%
17,568
+2,345
+15% +$16.1K
CVGI icon
2944
Commercial Vehicle Group
CVGI
$152M
$117K ﹤0.01%
18,202
+2,538
+16% +$15.4K
RES icon
2945
RPC Inc
RES
$1.14B
$117K ﹤0.01%
9,161
OXFD
2946
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$117K ﹤0.01%
8,318
+3,216
+63% +$43.8K
BOX icon
2947
Box
BOX
$4.36B
$116K ﹤0.01%
+5,893
New +$111K
SPA
2948
DELISTED
Sparton
SPA
$116K ﹤0.01%
4,720
+778
+20% +$18.6K
MVNR
2949
DELISTED
MAVENIR SYS INC COM STK (DE)
MVNR
$116K ﹤0.01%
6,534
+1,157
+22% +$17.4K
CCBG icon
2950
Capital City Bank Group
CCBG
$904M
$115K ﹤0.01%
7,097
+986
+16% +$15.1K

Similar funds

BlackRock Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, BlackRock Advisors held 3,772 positions worth $97.6B, down 1.7% from $99.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors withdrew a net $3.16B in Q1 2015, closing 154 positions and reducing 812 holdings. Its most notable exit was Allergan Inc, an estimated $199M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

Against the trend, BlackRock Advisors opened a new position in Mobileye N.V. worth $252M.

  • BlackRock Advisors's largest Q1 2015 buy was Mobileye N.V.: 6,000,666 shares worth $252M.
  • BlackRock Advisors added most to UnitedHealth in Q1 2015, an estimated $461M increase.
  • BlackRock Advisors's biggest Q1 2015 reduction was Chevron, cutting an estimated $382M.
  • BlackRock Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $199M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $97.6B portfolio in Q1 2015.
  • BlackRock Advisors opened 78 new positions and closed 154 in Q1 2015.
  • BlackRock Advisors's portfolio value fell 1.7% quarter-over-quarter to $97.6B.

Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.